These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10899847)

  • 1. Safety and immunogenicity of two different lots of the oral, killed enterotoxigenic escherichia coli-cholera toxin B subunit vaccine in Israeli young adults.
    Cohen D; Orr N; Haim M; Ashkenazi S; Robin G; Green MS; Ephros M; Sela T; Slepon R; Ashkenazi I; Taylor DN; Svennerholm AM; Eldad A; Shemer J
    Infect Immun; 2000 Aug; 68(8):4492-7. PubMed ID: 10899847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent circulating immunoglobulin A antibody-secreting cell and serum antibody responses in Swedish volunteers to an oral inactivated enterotoxigenic Escherichia coli vaccine.
    Jertborn M; Ahrén C; Svennerholm AM
    Clin Diagn Lab Immunol; 2001 Mar; 8(2):424-8. PubMed ID: 11238232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi children 18-36 months of age.
    Qadri F; Ahmed T; Ahmed F; Bradley Sack R; Sack DA; Svennerholm AM
    Vaccine; 2003 Jun; 21(19-20):2394-403. PubMed ID: 12744870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli vaccine.
    Jertborn M; Ahrén C; Holmgren J; Svennerholm AM
    Vaccine; 1998; 16(2-3):255-60. PubMed ID: 9607039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of an oral, killed enterotoxigenic Escherichia coli-cholera toxin B subunit vaccine in Egyptian adults.
    Savarino SJ; Brown FM; Hall E; Bassily S; Youssef F; Wierzba T; Peruski L; El-Masry NA; Safwat M; Rao M; Jertborn M; Svennerholm AM; Lee YJ; Clemens JD
    J Infect Dis; 1998 Mar; 177(3):796-9. PubMed ID: 9498468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-secreting cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine.
    Wennerås C; Svennerholm AM; Ahrén C; Czerkinsky C
    Infect Immun; 1992 Jul; 60(7):2605-11. PubMed ID: 1612730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein.
    Lundgren A; Leach S; Tobias J; Carlin N; Gustafsson B; Jertborn M; Bourgeois L; Walker R; Holmgren J; Svennerholm AM
    Vaccine; 2013 Feb; 31(8):1163-70. PubMed ID: 23306362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of systemic antifimbria and antitoxin antibody responses in Egyptian children and adults by an oral, killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine.
    Hall ER; Wierzba TF; Ahrén C; Rao MR; Bassily S; Francis W; Girgis FY; Safwat M; Lee YJ; Svennerholm AM; Clemens JD; Savarino SJ
    Infect Immun; 2001 May; 69(5):2853-7. PubMed ID: 11292698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal antibody response after oral immunization with a prototype cholera B subunit-colonization factor antigen enterotoxigenic Escherichia coli vaccine.
    Ahrén C; Wennerås C; Holmgren J; Svennerholm AM
    Vaccine; 1993; 11(9):929-34. PubMed ID: 8212839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced doses of oral killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine is safe and immunogenic in Bangladeshi infants 6-17 months of age: dosing studies in different age groups.
    Qadri F; Ahmed T; Ahmed F; Begum YA; Sack DA; Svennerholm AM;
    Vaccine; 2006 Mar; 24(10):1726-33. PubMed ID: 16257098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study.
    Lundgren A; Bourgeois L; Carlin N; Clements J; Gustafsson B; Hartford M; Holmgren J; Petzold M; Walker R; Svennerholm AM
    Vaccine; 2014 Dec; 32(52):7077-84. PubMed ID: 25444830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine: results of the initial evaluation in children. PRIDE Study Group.
    Savarino SJ; Hall ER; Bassily S; Brown FM; Youssef F; Wierzba TF; Peruski L; El-Masry NA; Safwat M; Rao M; El Mohamady H; Abu-Elyazeed R; Naficy A; Svennerholm AM; Jertborn M; Lee YJ; Clemens JD
    J Infect Dis; 1999 Jan; 179(1):107-14. PubMed ID: 9841829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enteral immunization and challenge of volunteers given enterotoxigenic E. coli CFA/II encapsulated in biodegradable microspheres.
    Tacket CO; Reid RH; Boedeker EC; Losonsky G; Nataro JP; Bhagat H; Edelman R
    Vaccine; 1994 Nov; 12(14):1270-4. PubMed ID: 7856290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. Coli diarrhoea of travellers to Guatemala and Mexico.
    Sack DA; Shimko J; Torres O; Bourgeois AL; Francia DS; Gustafsson B; Kärnell A; Nyquist I; Svennerholm AM
    Vaccine; 2007 May; 25(22):4392-400. PubMed ID: 17448578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi adults and children.
    Qadri F; Wennerâs C; Ahmed F; Asaduzzaman M; Saha D; Albert MJ; Sack RB; Svennerholm A
    Vaccine; 2000 Jun; 18(24):2704-12. PubMed ID: 10781858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-replicating oral whole cell vaccine protective against enterotoxigenic Escherichia coli (ETEC) diarrhea: stimulation of anti-CFA (CFA/I) and anti-enterotoxin (anti-LT) intestinal IgA and protection against challenge with ETEC belonging to heterologous serotypes.
    Evans DG; Evans DJ; Opekun AR; Graham DY
    FEMS Microbiol Immunol; 1988 Dec; 1(3):117-25. PubMed ID: 3078739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the safety and immunogenicity of the oral inactivated multivalent enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi adults in a double-blind, randomized, placebo-controlled Phase I trial using electrochemiluminescence and ELISA assays for immunogenicity analyses.
    Akhtar M; Chowdhury MI; Bhuiyan TR; Kaim J; Ahmed T; Rafique TA; Khan A; Rahman SIA; Khanam F; Begum YA; Sharif MZ; Islam LN; Carlin N; Maier N; Fix A; Wierzba TF; Walker RI; Bourgeois AL; Svennerholm AM; Qadri F; Lundgren A
    Vaccine; 2019 Sep; 37(37):5645-5656. PubMed ID: 30473185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introductory evaluation of an oral, killed whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Egyptian infants.
    Savarino SJ; Hall ER; Bassily S; Wierzba TF; Youssef FG; Peruski LF; Abu-Elyazeed R; Rao M; Francis WM; El Mohamady H; Safwat M; Naficy AB; Svennerholm AM; Jertborn M; Lee YJ; Clemens JD;
    Pediatr Infect Dis J; 2002 Apr; 21(4):322-30. PubMed ID: 12075764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative safety and immunogenicity of two attenuated enterotoxigenic Escherichia coli vaccine strains in healthy adults.
    McKenzie R; Bourgeois AL; Engstrom F; Hall E; Chang HS; Gomes JG; Kyle JL; Cassels F; Turner AK; Randall R; Darsley M; Lee C; Bedford P; Shimko J; Sack DA
    Infect Immun; 2006 Feb; 74(2):994-1000. PubMed ID: 16428745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and phase I clinical evaluation of the safety and immunogenicity of a candidate enterotoxigenic Escherichia coli vaccine strain expressing colonization factor antigen CFA/I.
    Turner AK; Beavis JC; Stephens JC; Greenwood J; Gewert C; Thomas N; Deary A; Casula G; Daley A; Kelly P; Randall R; Darsley MJ
    Infect Immun; 2006 Feb; 74(2):1062-71. PubMed ID: 16428753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.